Celltrion's Coronavirus Self-test Kit Gets FDA Emergency Approval | Be Korea-savvy

Celltrion’s Coronavirus Self-test Kit Gets FDA Emergency Approval


This imaged, provided by South Korean biopharmaceutical company Celltrion Inc. on Oct. 25, 2021, shows its DiaTrust COVID-19 Ag Home Test.

This imaged, provided by South Korean biopharmaceutical company Celltrion Inc. on Oct. 25, 2021, shows its DiaTrust COVID-19 Ag Home Test.

SEOUL, Oct. 25 (Korea Bizwire)South Korean biopharmaceutical company Celltrion Inc. said Monday that its self-diagnostic kit for the novel coronavirus has won emergency approval from U.S. drug authorities.

Celltrion DiaTrust COVID-19 Ag Home Test, co-developed by local healthcare business Humasis, received the U.S. Food and Drug Administration’s Emergency Use Authorization approval.

The product uses an antibody that specifically binds to the COVID-19 virus and detects infection within 15 minutes, Celltrion said. It is most suitable for identifying acute or early infection of the COVID-19 virus.

Celltrion USA, which handles Celltrion’s overseas business, will be responsible for the sales.

The self-test kit has also won approval for emergency use by other countries, including South Korea. It is also used in several European countries.

(Yonhap)

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>